Scout Investments’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-934
Closed -$223K 326
2017
Q1
$223K Sell
934
-1,490
-61% -$347K 0.01% 298
2016
Q4
$509K Buy
2,424
+223
+10% +$46.2K 0.01% 270
2016
Q3
$507K Buy
+2,201
New +$538K 0.01% 262
2016
Q1
Sell
-1,272
Closed -$397K 332
2015
Q4
$397K Sell
1,272
-720
-36% -$214K 0.01% 266
2015
Q3
$541K Buy
1,992
+196
+11% +$60.2K 0.01% 246
2015
Q2
$545K Buy
1,796
+276
+18% +$82.3K 0.01% 249
2015
Q1
$452K Hold
1,520
0.01% 252
2014
Q4
$391K Buy
1,520
+41
+3% +$10.2K 0.01% 251
2014
Q3
$357K Hold
1,479
﹤0.01% 249
2014
Q2
$330K Buy
+1,479
New +$306K ﹤0.01% 254

Other funds holding AGN

Scout Investments's AGN Position: Q2 2017 in Review

Scout Investments sold out of Allergan plc (AGN) in Q2 2017, closing a stake of 934 shares — an estimated $223K sold.

Scout Investments first reported a position in AGN in Q2 2014 and held it in 10 quarters. The position peaked at $545K in Q2 2015. 1,115 funds tracked by Wall St. Rank hold AGN as of Q2 2017.

  • Scout Investments reported no remaining Allergan plc position as of Q2 2017 after selling out during the quarter.
  • Scout Investments sold 934 Allergan plc shares in Q2 2017, an estimated $223K.
  • Scout Investments first reported a position in Allergan plc in Q2 2014 and held it in 10 quarters.
  • Scout Investments's Allergan plc position peaked at $545K in Q2 2015.
  • 1,115 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.

Based on Scout Investments's 13F filing for Q2 2017, filed 8 Aug 2017.